N
MEDP icon

Natixis’s Medpace MEDP Stock Holding History

Natixis’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,948
Closed -$3.82M – 1293
2026
Q1 		$3.82M Buy
7,948
+7,902
+17,178% +$4.05M 0.01% 479
2025
Q4 		$25.8K Buy
+46
New +$26.1K ﹤0.01% 1026
2025
Q3 		– Sell
-172
Closed -$54K – 1162
2025
Q2 		$54K Buy
172
+85
+98% +$25.5K ﹤0.01% 877
2025
Q1 		$25.8K Buy
+87
New +$29.3K ﹤0.01% 860
2024
Q3 		– Sell
-9
Closed -$3.71K – 1057
2024
Q2 		$3.71K Sell
9
-1,791
-100% -$709K ﹤0.01% 917
2024
Q1 		$727K Buy
+1,800
New +$633K ﹤0.01% 572

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Natixis's MEDP Position: Q2 2026 in Review

Natixis sold out of Medpace (MEDP) in Q2 2026, closing a stake of 7,948 shares — an estimated $3.82M sold.

Natixis first reported a position in MEDP in Q1 2024 and held it in 6 quarters. The position peaked at $3.82M in Q1 2026. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Natixis reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Natixis sold 7,948 Medpace shares in Q2 2026, an estimated $3.82M.
  • Natixis first reported a position in Medpace in Q1 2024 and held it in 6 quarters.
  • Natixis's Medpace position peaked at $3.82M in Q1 2026.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.